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Abstract
Endothelial cells are remarkably heterogeneous in both morphology and function, and they play critical roles in the
formation of multiple organ systems. In addition endothelial cell dysfunction can contribute to disease processes, including
diabetic nephropathy, which is a leading cause of end stage renal disease. In this report we define the comprehensive gene
expression programs of multiple types of kidney endothelial cells, and analyze the differences that distinguish them.
Endothelial cells were purified from Tie2-GFP mice by cell dissociation and fluorescent activated cell sorting. Microarrays
were then used to provide a global, quantitative and sensitive measure of gene expression levels. We examined renal
endothelial cells from the embryo and from the adult glomerulus, cortex and medulla compartments, as well as the
glomerular endothelial cells of the db/db mutant mouse, which represents a model for human diabetic nephropathy. The
results identified the growth factors, receptors and transcription factors expressed by these multiple endothelial cell types.
Biological processes and molecular pathways were characterized in exquisite detail. Cell type specific gene expression
patterns were defined, finding novel molecular markers and providing a better understanding of compartmental
distinctions. Further, analysis of enriched, evolutionarily conserved transcription factor binding sites in the promoters of co-
activated genes begins to define the genetic regulatory network of renal endothelial cell formation. Finally, the gene
expression differences associated with diabetic nephropathy were defined, providing a global view of both the pathogenic
and protective pathways activated. These studies provide a rich resource to facilitate further investigations of endothelial
cell functions in kidney development, adult compartments, and disease.
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Introduction
Endothelial cells play essential roles in both development and
disease. During development there is a crucial cross talk with
surrounding tissues. Heterotopic transplantation studies show that
organ specific microenvironments drive the specificity of vascula-
ture formed. For example peripheral blood vessels that penetrate a
graft of brain tissue form tight junctions, typical of brain vessels
[1]. Conversely, signals from endothelial cells have been shown to
be essential during the development of multiple organ systems,
including the heart [2], pancreas [3], liver [4], and kidneys [5].
There exist a tremendous variety of endothelial cell types, and we
are only beginning to understand their diverse functions [6].
Endothelial cell dysfunction can also play a primary role in
disease, including diabetic nephropathy [7]. Type 2 diabetes is an
increasingly important global health threat. In the United States the
prevalence of type 2 diabetes has almost doubled in the past 25
years, and in Asia the rate of increase is even more dramatic [8].
Diabetes is now the most common cause of end stage renal disease
in both developed and emerging nations [9]. All three cell types of
the glomerulus have been strongly implicated in diabetic nephrop-
athy. The mesangial cells produce the observed mesangial matrix
expansion. Altered podocyte function, including podocyte loss, foot
process effacement,andaltered makeupoftheglomerular basement
membrane (GBM), result in increased protein leakage. In addition
altered endothelial cell function has been associated with increased
leukocyte recruitment [10], increased angiogenesis leading to the
formation of immature and leaky vessels [11], and decreased
production ofactivatedproteinC,whichnormallyinhibitspodocyte
and endothelial cell apoptosis [12].
Important insight into both disease and normal developmental
processes can be gained by gene expression profiling. Microarrays
provide a comprehensive, sensitive and quantitative measure of
gene expression. Their global readout of gene use gives a detailed
picture of expressed transcription factors, growth factors, and
receptors. Early pioneering studies used microarrays to examine
changing gene expression patterns of entire kidneys from the rat as
a function of developmental time [13], followed by similar work
with mouse [13,14]. In some cases it was possible to use manual
microdissection or FACS to define gene expression profiles of
selected specific structures or cell types [14,15,16]. We have
previously described a gene expression atlas of kidney develop-
ment, at microanatomic resolution [17]. We primarily used laser
capture microdissection to isolate most of the multiple components
of the developing kidney. Microarrays were then used to define
gene expression patterns. The results defined the changing waves
of gene usage as a function of nephrogenesis. In addition, novel
molecular markers of specific compartments were found. Further,
by examining the concordance of changing transcription factor
expression with the presence of evolutionarily conserved tran-
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genes it was possible to begin to generate a genetic regulatory
network of kidney development.
In this study we extend this previous work by investigating the
gene expression programs of kidney endothelial cells. In particular,
we first defined the gene expression profile of endothelial cells from
E15.5 embryonic kidneys, to better understand the genetic
program that drives the formation of the renal vascular system.
We also examined the gene expression patterns of the adult
glomerular, medullary, and cortical endothelial cells, to discover
the molecular basis of their compartment specific properties.
Finally, to better define the molecular anatomy of diabetic
nephropathy, we analyzed the altered gene expression patterns
of glomerular endothelial cells in db/db mutant mice, which
represent a useful model of this disease.
Results and Discussion
Gene expression profile comparisons.
We used Tie2-GFP transgenic mice to purify endothelial cells
from E15.5 embryonic kidneys, adult medulla, adult glomeruli,
adult cortex (with glomeruli removed), and adult glomeruli of
db/db mice, which, again, represent a mouse model for diabetic
nephropathy. Glomeruli were purified by sieving. Tissues were
rapidly dissociated using a combination of enzymatic digestion and
trituration, followed by FACS isolation of GFP positive cells.
Affymetrix Mouse Gene 1.0 ST arrays were used to provide
global, sensitive and quantitative measures of gene expression. In
each case at least three independent biological samples were
examined. The results yield a universal view of the gene expression
programs used by these distinct types of endothelial cells.
A profile plot provides an overview of the observed differences
in gene expression (Fig. 1). The array data was analyzed with
GeneSpring GX11.01, RMA normalized, and only probesets with
a minimum 100 raw expression level in three samples were
included. Following ANOVA analysis, P,0.05, we selected for a
minimum five fold difference in expression level in any pairwise
sample type comparison, thereby identifying 786 probesets with
the most distinct expression patterns (Fig. 1)(Supplementary Data
S1). The embryonic endothelial cells showed the most distinct
gene expression signature, while the adult glomerular endothelial
cells from normal and db/db mice were most similar.
Embryonic endothelial cells
We first compared embryonic to adult endothelial cell gene
expression profiles, to better define the gene expression program of
renal vascular development. Screening for genes with at least four
fold difference in expression between E15.5 and normal adult
(glomerular, cortical and medullary) endothelial cells and further
requiring higher expression in embryonic samples, to focus on
genes driving the embryonic endothelial program, identified 340
probe sets (Supplementary Data S2). Gene ontology biological
process analysis, using ToppGene, identified forty processes with P
values listed as zero, and all were related to cell division
(Supplemental Data S3). They included, for example, M phase,
cell cycle, mitosis, nuclear division, cell division, DNA replication,
regulation of cell cycle, and so on. Not unexpectedly, the results
showed clearly that the embryonic endothelial cells are heavily
committed to cell division, while adult cells are not.
Embryonic endothelial cells compared to other
embryonic compartments
It is perhaps more instructive to compare the gene expression
profile of the embryonic endothelial cells to those of other
embryonic compartments, thereby identifying those genes specific
to vasculature formation. We therefore selected renal vesicles,
capping mesenchyme and ureteric bud for comparison. An
ANOVA analysis, including Benjamini and Hochberg correction,
corrected P,0.02, and fold change of at least three, gave 531
genes with strong expression differences in the four compartments.
A visual representation of the distinctive gene expression
signatures of these four compartments is shown in Fig. 2.
To capture a broader view of the genetic basis of embryonic
vasculogenesis we also performed a less stringent analysis,
requiring only a minimum two fold change (instead of three).
We focused on genes with elevated expression in endothelial cells
in all pairwise comparisons, yielding a total of 207 probe sets
(Supplemental Data S4), which were then subjected to functional
annotation using GeneSpring. The top biological processes to
emerge included angiogenesis (Elk3, Epas1, Egfl7, Eng, Sox18, Kdr,
Flt1, Robo4, Anxa2), regulation of cell migration (Abi3, Pecam1,
Egfl7, Tek, Tie2 and Robo4), and VEGF signaling pathway (Flt4,
Kdr, Flt1). Many of the genes on this list of 207, including Mef2c,
Ets1, endoglin, Fli1, Tie1, Flt1, Cdh5,Fflt4, Sox18, Erg, Epas1, Ahr,
Pecam1, and Icam2, have been previously strongly implicated in
endothelial cell development [18], providing historic validation of
the screen.
The expression data was further examined by performing a
molecular pathways analysis using GeneSpring. The results
showed a number of interesting interactions, with Tgfbeta1 and
Kdr occupying central positions (Fig. 3). Kdr encodes a tyrosine
kinase receptor for VEGF, and has been previously shown to
mediate endothelial cell proliferation, survival, migration, tubular
morphogenesis and sprouting [19]. Tgfbeta1 is also a well-
established modulator of angiogenesis [19].
These 207 genes can be divided into functional categories, with
DAVID identifying, for example, a group of 15 transcription
factors (Epas1, Nfib, Elk3, Erg, Fli1, Klf7, Ets1, Hhex, Sox18, Rnf141,
Bcl6b, Elf4, Ahr, Ostf1, Mefc2)(Supplemental Data S5). It is
interesting that three of these genes, Hhex, Bcl6b and Elf4, have
been shown to be involved in hematopoiesis [20,21,22]. This dual
endothelial-hematopoetic character strongly indicates the presence
of hemangioblasts, multipotent precursors able to differentiate into
both endothelial and hamatopoetic cells, in the E15.5 embryonic
kidney, as has been previously reported [23]. In addition, this
analysis identified 60 genes encoding membrane/receptor pro-
teins, many with previously established function in the develop-
ment and function of endothelial cells, as well as other functional
groups of genes.
A ToppGene functional analysis of the list of 207 genes with
elevated expression in embryonic endothelial cells gave similar
results, providing lists of genes involved in angiogenesis, vasculo-
genesis, blood vessel morphogenesis, response to oxygen levels,
hemopoiesis, and other biological processes these cells are engaged
in (Supplementary Data S6). In addition the ToppGene analysis
identified key evolutionarily conserved transcription factor binding
sites (RGAGGAARY-V$PU1_Q6, V$STAT6_02, V$STAT4_01,
V$ELF1_Q6, RYTTCCTG_V$ETS2_B and V$ETS2_B) en-
riched in the proximal promoter regions of multiple genes with
elevated expression (Supplementary Data S6). For example
conserved RYTTCCTG_V$ETS2_B binding sites were found
upstream of 25 genes (Egfl7, Rasgrp3, Tll1, Erg, Sgk1, Adpr, Prkch,
Myct1, Fxyd5, Vamp5, Ets1, Hhex, Sipa1, Lyn, ldb2, Gpr183, Adcy4,
Igf1, Mef2c, lcp1, Flt1, Elk3, Gpr97, Cdh5, Robo4). It is particularly
interesting that ETS binding sites emerge with extremely high
statistical significance, given the known vital role of ETS
transcription factors in vasculogenesis [24]. STAT binding sites
were also found with great frequency, again of interest because
Kidney Endothelial Cells
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involved in vasculogenesis [25,26]. Of interest, STAT3 is
expressed in the embryonic endothelial cells, but also in the other
endothelial cells, so it is not on the list of 207 genes with up
regulation in embryos. Its activity, of course, is regulated by Jak
mediated phosphorylation. These results begin to define a genetic
regulatory network driving development of the renal vasculature.
Glomerular specific endothelial genes
The glomerular endothelial cells (GEC) are striking in their
fenestrated structure, which facilitates fluid bypass to the
glomerular basement membrane. To better define the gene
expression signature specific to the adult GEC we compared their
gene expression profile to those of kidney medullary and cortical
(with glomeruli removed) enthothelial cells. The microarray data
screen included subtraction of low expressing genes, where raw
signal was not above at least 100 for three individual samples, an
ANOVA analysis, P,0.05, and requiring at least a four fold
elevated expression in endothelial cells of glomeruli compared to
both cortical and medullary endothelia. This stringent screen
identified twelve genes.
Scn7a showed the greatest fold change, with more than ten fold
elevated expression in GEC compared to both cortex (with
glomeruli removed) and medullary endothelial cells. This gene
encodes a membrane bound voltage gated member of the sodium
channel family. Endothelial cells are generally considered to be
electrically unexcitable, although there have been reports that that
this is not always the case [27,28]. In particular, it was shown that
in hamster feed arteries electrical stimulation of endothelial cells
can result in a vasodilation reponse [27]. This suggests the possible
presence of a novel electrical signaling pathway in the glomerulus.
The microarray data also showed the Ehd3 gene to be strongly
up regulated in GEC. Ehd3 encodes a protein involved in
endosome to golgi transport [29]. Of interest, this gene has been
previously shown to be expressed very specifically in the GEC,
providing additional historical validation of the microarray data
[30]. Indeed, this was the only gene, to our knowledge, previously
shown to be expressed by GEC and not other endothelial cells of
the kidney.
Another gene up regulated in GEC was Gata5, encoding a
transcription factor previously shown to be required for the
differentiation of cardiac endothelial cells [31]. We also observed a
dramatic up regulation of Sema5a, which has been shown to play a
critical role in branching patterning of the vascular system [31]. It
has also been shown to promote endothelial cell proliferation and
to protect against apoptosis [32]. Of further interest, the SEMA5A
protein includes seven thrombospondin repeats.
We also found elevated GEC expression of the Adamts5 gene,
which encodes a disintegrin like and metalloprotease with
thrombospondin domains. This gene has previously been shown
to be expressed in the endothelial cells of the adult cornea [33].
The first thrombospondin repeat, but not the second, functions as
an inhibitor of angiogenesis [34]. Another GEC elevated gene,
Gimap3, encodes a GTPase previously implicated in the control of
cell survival [35].
Nostrin also showed much higher expression in GEC than other
endothelial cells of the kidney. It encodes a protein that binds the
enzyme responsible for NO synthesis, endothelial NO synthase,
and triggers its translocation from the plasma membrane to
vesicle-like subcellular structures, thus attenuating NO produc-
tion. For a complete list of genes up regulated in GEC see
Supplementary Data S7.
It is perhaps surprising that so few genes are strongly GEC
specific in expression. In this regard it is interesting to note that the
formation of fenestrae has been clearly linked to VEGF signaling,
PI3 kinase activation and actin rearrangements [36], in a pathway
that might involve relatively little de novo gene expression.
Medullary specific endothelial genes
The renal medulla presents extreme conditions, with low
oxygen tension and high concentrations of the solutes NaCl and
urea in antidiuresis. The cells of the medulla employ a variety of
mechanisms to survive this hostile environment [37]. We
specifically examined the gene expression profile of the medullary
endothelial cells in comparison to the glomerulus and cortex.
Using the same microarray data screening procedure described for
the glomerular compartment, only requiring five fold upregulation
instead of four, fourteen genes were identified with elevated
expression in medullary endothelial cells, as described below.
Insulin-like growth factor 1 (Igf1) expression was the most
specific to medullary endothelial cells, elevated 15 fold and 28 fold
compared to cortical and glomerular compartments, respectively.
Igf1 is implicated in neovasculartization [38], migration and
angiogenesis of endothelial cells [39]. Of interest, it induces
hypoxia-inducible factor 1 mediated VEGF expression in colon
cancer cells [40]. Other elevated genes were Tll1, required for
normal heart development and vasculogenesis [41], and Tmem195,
encoding a transmembrane protein. In addition there was
medullary endothelial cell specific expression of the Cd36 receptor
gene, whose encoded protein interacts with a large variety of
ligands, including collagen types I and IV, thrombospondin,
platelet-agglutinating protein p37, oxidized low density lipopro-
tein, and long-chain fatty acids.
It is interesting to note that Pde7b and Agtrl1 both normally
showed restricted expression in the medullary endothelial cells, but
were observed to be upregulated in the diabetic nephropathy
GEC, as discussed later.
Other genes with medullary elevated expression included Mmp-
11, encoding a matrix metalloproteinase, previously reported
localized surrounding endothelial cells of glioblastomas [42], We
also observed elevated medullary endothelial cell expression of
Angpt2, which is normally expressed at sites of vascular remodeling,
and functions as an antagonist of the angiogenic functions of
angiopoietin1 and TIE2 [43]. See Supplementary Data S8 for a
complete gene list.
Cortical endothelial cells
Of interest, while relatively few genes showed glomerular or
medullary endothelial cell specific expression with the stringent
screen employed, a similar screen for cortical endothelial cell
specific gene expression resulted in a much larger number, 125
genes (see Supplemental Data S9). Further analysis of this gene set
gave a surprising result, with the gene expression signature
resembling that previously described for proximal tubules [17].
For example, there were twenty five transporter genes, with almost
all previously shown to have very strong proximal tubule specific
expression (GUDMAP.org). The data, therefore, indicated that
there was a minor contamination of the cortical endothelial cells
and that when the expression patterns of the medulla and
glomerular endothelial cells were subtracted the remainder was
cells from adult kidney cortex, with glomeruli removed, Medullary, adult medulla compartment endothelial cells, wt Glom, control adult
glomerulus compartment endothelial cells, db Glom, adult glomerulus compartment endothelial cells from db/db mouse with diabetic nephropathy.
doi:10.1371/journal.pone.0012034.g001
Kidney Endothelial Cells
PLoS ONE | www.plosone.org 4 August 2010 | Volume 5 | Issue 8 | e12034primarily a proximal tubule profile. Even a small contamination
would be revealed by the comparative analysis performed, with
genes showing high expression in contaminating cells showing up
when the endothelial gene expression pattern was removed.
Nevertheless, the cortical endothelial data set was useful for the
purpose of screening the glomerular and medulla profiles for
compartment specific gene expression. It served to subtract
cortical endothelial expressed genes, even though some additional
proximal tubule expressed genes were also represented.
We examined the other data sets for signs of similar
contamination. For example GEC might be particularly prone
to contamination with podocytes and mesangial cells, the
remaining two major cell types of the glomerulus. Other cell
varieties would be effectively removed by the initial sieving
procedure used to purify the glomeruli. Two specific markers of
podocytes and mesangial cells are Mafb and Meis1, respectively.
These genes showed low expression levels in the GEC samples,
indicating a high level of purity.
Comparison of glomerular endothelial cells of normal
and db/db mice
To better understand the molecular basis of diabetic nephrop-
athy we compared the wild type and db/db GEC gene expression
profiles. The db/db mice, with loss of function of the leptin receptor
gene, suffer obesity, diabetes, and diabetic nephropathy. The db/
db mice show many similarities to human diabetic nephropathy,
including elevated glucose levels, glomerular hypertrophy, mes-
angial matrix expansion and albuminuria [44,45]. We evaluated
the db/db mice when seven months of age, at which point they
exhibited profound obesity (63.162.6 grams compared to
39.162.4 grams for non db/db littermates), elevated blood sugar
(730265258 mg/dL versus 4764.2 for controls), and albuminuria
(391161288.5 mg/ml/24 hr versus 32.365.3 for controls). At this
point the glomeruli showed significant enlargement (Fig. 4). We
analyzed the relatively early stages of the disease process to better
understand the initiating events. The glomeruli were, as before,
first purified by sieving, followed by cell dissociation and FACS, to
isolate the Tie2-GFP positive endothelial cells.
We initially used a relatively low stringency screen of the
resulting microarray data, performing an unpaired t-test, P,0.05,
finding a total of 267 probesets with greater than 1.5 fold change
in expression (Supplemental Data S10). ToppGene was then used
for functional analysis, with the following interesting results.
The three gene ontology molecular functions listed with the
lowest P-values were all related to phosphodiesterase activity
(P=0.0001–0.0002), suggesting altered cAMP levels in the db/db
endothelial cells. The biological processes that emerged with
lowest P values were cell adhesion and biological adhesion, with 26
genes each (P=0.00003). Additional biological processes identified
were response to external stimulus, cellular extravasation,
heterophilic cell adhesion, cell adhesion, biological adhesion,
leukocyte adhesion, inflammatory response, and leukocyte tether-
ing and rolling. ToppGene also identified several conserved
transcription factor binding sites within the promoters of genes
with altered expression, including V$STST5B_01 upstream of
Klf4, Pcolce, Adamts9, Nfil3, Ndst1, Pdlim1 and Icam1. In addition,
micro RNAs that target significant numbers of genes changed in
expression in db/db GEC were found, including for example mir-
Figure 2. Heat Map displaying gene expression differences
(531 probe sets) between different kidney development
compartments. Shown are End (E15.5 endothelial cells), UB (E11.5
ureteric bud), CM (P0 capping mesenchyme), and RV (P4 renal vesicle).
doi:10.1371/journal.pone.0012034.g002
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complete lists of genes associated with specific biological processes
and functions, as well as targets of transcription factors and
microRNAs see Supplementary Data S11.
The top 22 genes
A more stringent screen of the data, requiring at least three fold
change in expression in db/db GEC, reduced the list of genes to
twenty two (Fig. 5). The observed differences in expression levels
were highly reproducible. Of interest, several of the genes on this
list have been previously shown to be endothelial cell type specific
and/or connected to the diabetic nephropathy disease process, in
either a protective or pathologenic role. Some of these genes, and
others with smaller fold change yet of particular interest, are
described below.
Cell adhesion molecules
Macrophages appear to play a key role in the pathogenesis of
diabetic nephropathy [46,47]. In particular, in the db/db mouse
glomerular macrophage accumulation was previously shown to
correlate well with the progression of glomerular damage [48].
Cell adhesion molecules expressed by endothelial cells can
contribute to the pathogenesis of diabetic nephropathy by
promoting the binding and infiltration of leukocytes. We observed
elevated Icam, and Vcam1 in the DB glomerular endothelial cells.
This likely contributes to diabetic nephropathy pathogenesis since
Icam1 deficient mice have been reported resistant to diabetes
induced renal injury [49], as a result of suppressed macrophage
infiltration. It has also been shown that db/db mice with Icam
deficiency have significantly reduced level of albuminuria, fewer
glomerular and interstitial macrophages, and less glomerular
hypetrophy, hypercellularity and tubular damage [50]. Two other
cell adhesion molecules, p-selectin and e-selectin, also involved in
leukocyte recruitment, have been reported elevated in the
endothelial cells of patients with diabetic nephropathy [51,52].
We observed an approximate two fold increase in p-selectin
transcript levels in the endothelial cells of the db/db mice, and a
nine fold elevation for e-selectin.
BMP
One of the hallmarks of diabetic nephropathy is a reduction in
the number of podocytes and expression of podocyte markers [53].
Decreased BMP signaling has been proposed to play a key role in
podocyte injury and loss. In particular, in diabetic nephropathy
podocytes produce connective tissue growth factor (CTGF), an
inhibitor of BMP signaling [54]. Furthermore, BMP7 has been
Figure 3. Molecular pathways analysis of genes with elevated expression in the kidney developing endothelial compartment.
Generated with GeneSpring 11.0 using the 207 genes with elevated expression in the embryonic endothelial cells. Relations between encoded
proteins are shape and color coded, with dark purple square = member, light blue triangle = transport, red square = expression, purple square =
regulation, blue square = binding, orange circle = promoter binding, light blue diamond = metabolism, pink = protein modification.
doi:10.1371/journal.pone.0012034.g003
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streptozotocin treated rats [55] and mice [56,57].
The microarray data showed significant expression of Bmp6 in
the normal GECs, with high raw expression values of over 1000.
Furthermore, the expression level was elevated about 1.6 fold in
the db/db mouse (P=0.03). This increased BMP expression might
afford the podocytes some level of protection.
Another gene showing significant up regulation (3.4 fold) in the
db/db endothelial cells was BMP binding endothelial regulator,
Bmper, which is a secreted modulator of BMP signaling [58]. It is
expressed in endothelial cells, as the name suggests, and can bind
BMP2, BMP4 and BMP6 [58]. In the developing mouse BMPER
appears to have primarily a ‘‘pro-BMP’’ function, with the
knockout mouse showing developmental defects resembling those
of BMP knockouts, including a smaller kidney with reduced
nephron counts [59]. The elevated BMPER expression of the
diabetic nephropathy GECs, combined with the increased Bmp6
expression, would be predicted to promote health and survival of
the neighboring podocytes.
TGF
While BMP expression is considered protective, increased
TGFb expression plays a central role in the pathogenesis of
diabetic nephropathy. TGFb promotes renal cell hypertrophy
and extracellular matrix accumulation, two key features of
diabetic nephropathy. Indeed, although perhaps extreme, it has
been stated that ‘‘TGFb has been shown to mediate virtually all
of the pathologic changes of diabetic kidney disease.’’ [60].
Furthermore, treatment with anti TGFb antibody has been
shown to reduce or prevent hypertrophy and extracellular matrix
expansion in both strptozotocin-induced diabetic mice [61], and
db/db mice [62].
We observed a 1.5 fold increase of TGFb1 expression in db/db
endothelial cells, with raw expression levels of around 375 in wild
type (uncorrected P=0.03) in GEC, while there was no significant
change in TGFb 2 or 3. Of interest, we also observed a modest
upregulation (1.4 fold, uncorrected P= 0.006) of Smad3, a
mediator of TGFb signaling, suggesting a possible autocrine effect.
Thrombomodulin
Glomerular endothelial cells express thrombomodulin, a
receptor for thrombin. The binding of thrombin to thrombomo-
dulin creates a complex that activates protein C, which in turn has
anti-inflammatory and anti-apoptotic protective properties. Iser-
mann et al (2007) reported that mice with streptozotocin induced
diabetes showed reduced glomerular endothelial cell expression of
thrombomodulin [12]. Further, they showed that genetic reduc-
tion of thrombomodulin function resulted in more severe
proteinuria and extracellular matrix accumulation, while trans-
gene expression of activated protein C protected against diabetic
nephropathy. Consistent with these findings we observed high
expression levels of thrombomodulin in wild type glomerular
endothelial cells, with raw expression levels of about 1900, and a
1.5 fold down-regulation of expression in the db/db mice. This
could in part account for reduced levels of activated protein C
observed in diabetic nephropathy, and could contribute to
pathogenesis.
Apelin and APJ
The gene showing the second greatest fold change (7.8 fold
up regulated) in the db/db glomerular endothelium was Agtrl1,
angiotensin receptor like 1, also known as the APJ receptor. Apelin
is an ang II homologue and is the ligand for the G-coupled
receptor APJ.
APJ mutant mice show an enhanced vasopressor response to
angiotensin II, suggesting that apelin-APJ counteracts renin-
angiotensin [63]. AngII has been thought an important mediator
of diabetic kidney damage, promoting vascular contraction,
stimulating growth factor, cytokine and reactive oxygen synthesis
(ROS) synthesis through the AT1 receptor. APJ has been localized
to both vascular smooth muscle and endothelial cells [64,65]. In
particular apelin-APJ has been shown to play a role in renal
hemodynamics, with apelin having a vasodilator effect that
reverses that of AngII in both afferent and efferent arterioles
[65,66]. In addition, the apelin mechanism was shown to require
endothelial APJ, to be mediated through NOS, and to result in
calcium concentration drops in arteriole smooth muscle [65],
Figure 4. Enlarged glomeruli in seven month old db/db mice. Panels A and C are controls, and panels B and D are from db/db mice. Panels A
and B are lower magnification views showing multiple glomeruli, while panels C and D are higher magnification, more clearly showing the size
difference. Sections were hematoxylin and eosin stained.
doi:10.1371/journal.pone.0012034.g004
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regulation of aortic vascular tone [67].
In the db/db endothelial cells APJ raw expression levels were
elevated about eight fold, to an extremely robust 3000. In some
cases the apelin-APJ pathway has been reported to be autocrine in
nature [68]. We observed low level apelin expression in wild type
glomerular endothelial cells, with raw expression levels of about
150, which was unchanged in db/db mice. While the cardiac
endothelium appears to be the major source of apelin [69], these
results show that it is not the exclusive source.
The overwhelming body of data argues that apelin-APJ provides
beneficial effects. APJ expression was previously shown reduced in
renal arteries of db/db mice by western blot [66], but we show
here, by microarray analysis of purified glomerular endothelial
Figure 5. Heat Map of twenty two genes showing the greatest change in expression in glomerulus endothelial cells of diabetic
nephropathy db/db mice. Red indicates high level of expression, and blue low expression, with yellow intermediate. C, control samples. DN,
diabetic nephropathy db/db mice. Nineteen of the genes were up regulated in db/db mice, and three genes were down regulated.
doi:10.1371/journal.pone.0012034.g005
Kidney Endothelial Cells
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there is actually a considerably elevated level of APJ specifically
within the endothelial cells of the glomerulus.
Apelin could be considered a potential therapeutic for diabetic
nephropathy, reversing AngII effects. In addition it might be
possible to identify a small molecule agonist of the APJ receptor,
which could also provide therapeutic benefit.
Apelin-APJ has been shown to be a regulator of nitric oxide
(NO) synthesis [70], with both RNA and protein levels of NO
elevated in apelin treated rat aortas [71]. Altered NO levels in turn
have been strongly associated with diabetic nephropathy, although
the many reports do not provide a completely consistent
clarification of the pathogenic and/or protective roles of NO
[72]. Of interest we observed no statistically significant change in
expression levels of nitrogen oxide synthase 1 (NOS1) (neuronal),
NOS2 (inducible) or NOS3 (endothelial) in the db/db glomerular
endothelial cells. Nevertheless, we cannot rule out the possibility
that APJ could be driving increased NO production through
altered NOS phosphorylation [70].
CD55
CD55 showed a very robust five fold elevation of expression in
the endothelial cells of db/db mice, going from a significant raw
expression level of 230 to over a thousand. CD55 is normally
expressed on essentially all cells that come into contact with
plasma complement proteins, and affords a protective effect. It
interrupts the complement cascade and thereby helps to prevent
complement mediated cell injury in inflammation. It is up
regulated by a number of cytokines, including Il1a, by VEGF
and by thrombin. Its increased expression in db/db endothelial
cells likely provides a shielding consequence.
Esm1
Esm1 (endothelial specific molecule 1) showed an up regulation
of about five fold in db/db endothelial cells, very similar to that
observed for CD55. Also, like CD55, it has been shown to be up
regulated by cytokines [73]. Of interest this elevated Esm1
expression does not appear to be restricted to the kidney, with a
similar 4 fold increase previously reported in the diaphragm of db/
db mice [74]. ESM1 has been implicated in lymphangiogenesis
and is potently induced by VEGF-A and VEGF-C [75]. ESM1 is a
proteoglycan secreted by endothelial cells, and although its precise
role is not known it has been proposed to inhibit the interaction
between ICAM-1 and the LFA-1 integrin on lymphocytes and
monocytes, thereby blocking cell adhesion [76].
Adamts9
ADAMTS9 is a secreted disintegrin and metalloprotease
carrying 15 thrombospondin type 1 repeats. The Adamts9 gene is
unusual in that the Affymetrix Mouse Gene 1.0 ST array used in
this study carries six independent probesets, with a total of over
150 independent 25mer oligonucleotide probes assaying expres-
sion. All six probesets showed a statistically significant up
regulation in db/db glomerular endothelial cells, with an average
fold change of 3.8. Members of the ADAMTS family have
previously been shown to be induced by inflammatory cytokines
and TGFbeta1 [76,77]. The elevated Adamts9 expression could
provide a disintegrin anticoagulant function, and it could help
counteract extracellular matrix accumulation, both protective
functions. But it could also contribute to glomerular basement
membrane breakdown and/or effacement of podocytes, both
pathologic functions. Of particular interest, ADAMTS9 has been
shown to have anti-angiogenic activity, with Adamts9 +/2
heterozygous mice showing spontaneous corneal neovasculariza-
tion [78]. Because of the importance of neovasculariztion in
diabetic nephropathy this suggests that Adamts9 elevated expres-
sion provides a protective function.
Fabp7, Gpihbp1
Fatty acid binding protein 7 (Fabp7) expression showed a four fold
up regulation in db/db GECs. It is interesting to note that Fabp7
was previously found expressed in a high percentage of clear renal
cell carcinomas [79]. Perhaps related, Gpihbp1 expression was also
up regulated about 4 fold. It has previously been shown to encode
an endothelial protein that plays a critical role in the lipolytic
processing of chylomicrons [80].
Serpina3g
The Serpina3g gene encodes a serine protease inhibitor and has
been shown to provide protective effect against caspase indepen-
dent cell death [81]. It is interesting to note that while serpina3g
expression was elevated 4.3 fold in the db/db mouse, its expression
level in the wild type mouse was relatively low. Serpine2, another
serine protease inhibitor, showed only a 2.5 fold increase in db/db
mice, but basal levels in wild type mice were higher, and as a result
so was the db/db expression level.
Pde7b
As mentioned previously, one of the most significantly altered
molecular functions in the db/db GECs was phophodiesterase
activity. Pde7b encodes a cAMP specific phosphodiesterase and was
upregulated 3.3 fold in the db/db glomerulus endothelial cells. Two
other cAMP specific phosphodiesterase genes, Pde4b and Pde4d, are
also upregulated, to a lesser extent, about 1.5 fold. Elevated
expression of these genes would work to drive down levels of
cAMP, which could contribute to a breakdown of endothelial
barrier properties, and modify responses to inflammatory
mediators [82,83].
Validation
We performed immunostains to further examine the microarray
predicted changes in gene expression. The products of five genes,
Esm1, Agtrl1 (APJ), Bmper, Adamts9 and Gpihbp1, with up regulation
in the db/db GECs were selected. As shown in Fig. 6, the proteins
encoded by these five genes all showed significant increases in
abundance in the db/db glomerulus. It is interesting to note that
four of these proteins (ESM1, BMPR, ADAMTS9, GPIHPB1) can
be secreted, so their final localizations may not necessarily coincide
with the endothelial compartment. In each case, however, we
observed consistent elevated expression in the db/db glomeruli.
It is also interesting to note that for three of the proteins,
AGTRL1, ADAMTS9 and GPIHBP1, there was a dramatic
increase at the vascular pole, as marked by the arrows in Fig. 6
panels D, H and K. This was highly reproducible, and not
observed in the control glomeruli from non db/db mice. This
correlates well with long standing observations demonstrating
neovascularization at the vascular pole of diabetic nephropathy
glomeruli [84,85,86,87]. This neovascularization has been found
even in diabetic patients during the first two years of disease,
indicating that it is an early event [84]. Our combined microarray
and immunostaining results suggest that this is a key region for
endothelial gene expression changes in diabetic nephropathy.
Summary
In summary, we defined the gene expression profiles of the
endothelial cells of the kidney during development, in distinct
adult compartments, and in the glomeruli of the db/db mouse,
Kidney Endothelial Cells
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nephropathy. The results provide a comprehensive and quantita-
tive analysis of gene use in these multiple endothelial cell
populations. They define all of the growth factors, receptors and
transcription factors expressed, and begin to explain the diverse
properties of these divergent endothelial cell types.
The observed gene expression changes in the glomerular
endothelial cells of the db/db mouse are perhaps of particular
interest. Diabetic nephropathy is a devastating disease that occurs
in approximately one third of diabetic patients [88]. A number of
important previous studies have used microarrays to begin to
dissect out the molecular mechanisms driving pathogenesis. Early
pioneering work used whole kidneys from db/db or streptozotocin
treated mice [89,90,91], and in two cases isolated glomeruli from
human samples [92,93]. In this report we were able to focus the
analysis to glomerular endothelial cells, to better define the gene
expression changes that occur in this precise compartment. The
results identified 267 genes with greater than 1.5 fold change in
gene expression, with molecular processes and biological functions
including phosphodiesterase activity and cell adhesion. In addition
Figure 6. Immunostain validation of gene expression differences in db/db glomerulus. Protein levels were examined in C (control) kidneys,
panels A, C, E, G and K, as well as DN (diabetic nephropathy) kidneys, panels B, D, F, H, and K. Elevated expression was observed in each case. Arrows
in panels D, H and K show striking signal in the vascular pole region for AGTRL1, ADAMTS9 and GPIHBP1. Arrowhead in panel D marks elevated
AGTRL1 expression also observed in tubules.
doi:10.1371/journal.pone.0012034.g006
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many of which could be related to either pathogenic or protective
roles in the disease process. These results give a deeper
understanding of diabetic nephropathy, and provide a valuable
resource to facilitate further investigations.
Material and Methods
Endothelial cell purification
Endothelial cells were purified from Tie2-GFP transgenic mice
using a previously described fluorescent activated cell sorting
procedure [17] (http://www.gudmap.org/Research/Protocols/
Potter.html). In brief, cells were quickly dissociated by a
combination of enzymatic digestion and trituration. For the
isolation of glomerular endothelial cells the glomeruli were first
purified using a sieving procedure (see below).
RNA Purification, Target Amplification, and Microarray
Hybridization
RNA was purified using a Qiagen RNeasy Micro kits and used
for a single round or RiboSpia target amplification using the
Nugen WT-Pico kit according to Nugen protocols. Hybridization,
washing and scanning of Affymetrix Mouse Gene 1.0 ST arrays
were performed according to standard Affymetrix procedures.
Microarray data analysis
Microarray data was analyzed as previously described [17],
primarily using GeneSpring software, version GX 11.0. Other
software used included ToppGene and DAVID. A standard
analysis used either ANOVA for multiple sample types, or an
unpaired t-test for two sample type comparisons. We removed
probsets with low raw expression levels, requiring at least 100 in
three samples. Probesets with low expression are particularly
prone to artifact difference calls. We then used a combination of
FDR, P value and fold change to adjust the stringency of the
screen, with specific criteria described for each example in the
text.
Isolation of glomeruli
Kidneys were isolated in ice-cold PBS, bisected, and the
medullary region was removed. The remaining cortical region was
minced into very small pieces and digested with 1.0% collagenase
at 37uC for 15 min, followed by vigorous trituration. An equal
volume of ice-cold 5% FBS/PBS was added and the mixture was
filtered through a 100 mm mesh. The flow-through was collected,
triturated vigorously and filtered through a 40 mm mesh. The
glomeruli trapped on the filter were isolated by turning the filter
over and rinsing with ice-cold 0.1% FBS/PBS. The collected
glomeruli were vigorously triturated and re-filtered through
40 mM mesh. This process was repeated three times. After the
final collection, the glomeruli were pelleted, washed with ice-cold
PBS and resuspended in 0.5% trypsin. The glomeruli were
incubated at 37uC for 10–15 min. During incubation, the
glomeruli were triturated every five min. A portion of the sample
was observed under a microscope to monitor cell dissociation.
After incubation, ice-cold 5% FBS/PBS was added, the cells were
pelleted, washed with ice-cold PBS and filtered before FACS
analysis.
Immunoflurescence
Kidneys were isolated in ice-cold PBS, fixed overnight in 4%
PFA/PBS, and then cryo-preserved at 4uC in 30% sucrose
overnight. Tissue was frozen in OCT (Tissue-Tek) for cryo-
sectioning. Slide mounted sections were incubated in PBS for
5 min, and blocked for 60 min in PBS containing 10% donkey
serum and 0.25% Triton X-100. The sections were washed 3X in
PBS containing 1% donkey serum and 0.25% Triton X-100
(PBST). The sections were incubated in PBST containing primary
antibody overnight at room temperature. After incubation, the
sections were washed in PBST 3 times, secondary antibody in
PBST was added, and incubated for 3 hours at room temperature.
Sections were washed 3X in PBST for 5 min, coverslipped in
Vectashield (Vector Labs) and imaged on a Zeiss AX10
microscope (Zeiss). All primary antibodies in this study were
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz CA.)
and secondary antibodies were obtained from Invitrogen (Carls-
bad, CA). All dilutions used were according to manufacturers
recommendations.
Ethics Statement
All mouse experiments were conducted in an AAALACS
approved animal facility in accordance with the Cincinnati
Children’s Hospital Medical Center Institutional Animal Care
and Use Committee policies, approved protocol number
OD02013.
Microarray data is available at the genitourinary development
atlas project web site (GUDMAP.ORG), and also through GEO
(GSE21324, GSE20004, GSE 11232, GSE 22561, GSE 22464,
GSE 20991). Experiments were conducted in a MIAME
compliant manner.
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